Filing Details
- Accession Number:
- 0001209191-21-008902
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-09 17:28:11
- Reporting Period:
- 2021-02-05
- Accepted Time:
- 2021-02-09 17:28:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1761612 | Bicycle Therapeutics Plc | BCYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776938 | Kevin Lee | C/O Bicycle Therapeutics Plc B900, Babraham Research Campus Cambridge X0 CB22 3AT | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-02-05 | 100 | $31.00 | 258,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
